Cargando…

Repurposing Antidiabetic Drugs for Cardiovascular Disease

Metabolic diseases and diabetes represent an increasing global challenge for human health care. As associated with a strongly elevated risk of developing atherosclerosis, kidney failure and death from myocardial infarction or stroke, the treatment of diabetes requires a more effective approach than...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schubert, Mario, Hansen, Sinah, Leefmann, Julian, Guan, Kaomei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522553/ https://www.ncbi.nlm.nih.gov/pubmed/33041865 http://dx.doi.org/10.3389/fphys.2020.568632

Ejemplares similares

Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing
por: de Anda-Jáuregui, Guillermo, et al.
Publicado: (2018)

Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
por: Olatunde, Ahmed, et al.
Publicado: (2021)

Role of Leptin in Cardiovascular Diseases
por: Poetsch, Mareike S., et al.
Publicado: (2020)

Repurposing Proteostasis-Modifying Drugs to Prevent or Treat Age-Related Dementia: A Systematic Review
por: Heard, Daniel S., et al.
Publicado: (2018)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

The Impact of Antidiabetic Therapies on Diastolic Dysfunction and Diabetic Cardiomyopathy
por: Gopal, Keshav, et al.
Publicado: (2020)

Cardiovascular outcomes and safety with antidiabetic drugs
por: Aldossari, Khaled K.
Publicado: (2018)

Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential
por: Suvarna, Kruthi, et al.
Publicado: (2021)

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
por: Qin, Chenxi, et al.
Publicado: (2023)

Repurposing drugs to treat cardiovascular disease in the era of precision medicine
por: Abdelsayed, Mena, et al.
Publicado: (2022)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Lo, Chris Wai Hang, et al.
Publicado: (2021)

Antidiabetic and Antihyperlipidemic Effects of Methanolic Extract of Leaves of Spondias mombin in Streptozotocin-Induced Diabetic Rats
por: Gobinath, Ramachawolran, et al.
Publicado: (2022)

Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual I(K1)
por: Meijer van Putten, Rosalie M. E., et al.
Publicado: (2015)

Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients
por: Vitiello, Libero, et al.
Publicado: (2018)

Caveolin as a potential drug target for cardiovascular protection
por: Sellers, Stephanie L., et al.
Publicado: (2012)

Repurposing of Glycine-Rich Proteins in Abiotic and Biotic Stresses in the Lone-Star Tick (Amblyomma americanum)
por: Bullard, Rebekah, et al.
Publicado: (2019)

Beyond Blood Sugar: Investigating the Cardiovascular Effects of Antidiabetic Drugs
por: Ahmad, Binish A, et al.
Publicado: (2023)

Comorbidity Networks in Cardiovascular Diseases
por: Cruz-Ávila, Héctor A., et al.
Publicado: (2020)

Autonomic Modulation for Cardiovascular Disease
por: Hadaya, Joseph, et al.
Publicado: (2020)

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
por: Michailidis, Michalis, et al.
Publicado: (2022)

Recent cardiovascular outcome trials of antidiabetic drugs: A comparative analysis
por: Singh, Awadhesh Kumar, et al.
Publicado: (2017)

Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
por: Chaffey, Laura, et al.
Publicado: (2022)

Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
por: Wang, Rui-Sheng, et al.
Publicado: (2023)

Ankyrins and Spectrins in Cardiovascular Biology and Disease
por: El Refaey, Mona M., et al.
Publicado: (2017)

Editorial: Diabetes, Hypertension and Cardiovascular Diseases
por: Choi, Soo-Kyoung
Publicado: (2021)

Editorial: Cardiovascular Remodeling in Aging and Disease
por: Steppan, Jochen, et al.
Publicado: (2022)

Editorial: Mitochondrial disorders and cardiovascular diseases
por: Zhang, Quanjiang, et al.
Publicado: (2023)

Multi-Target Drugs for Blood Cancer in the Elderly: Implications of Damage and Repair in the Cardiovascular Toxicity
por: Madonna, Rosalinda
Publicado: (2021)

How to Assess the Epistemic Wrongness of Sponsorship Bias? The Case of Manufactured Certainty
por: Leefmann, Jon
Publicado: (2021)

Prognostic Indicators of Cardiovascular Risk in Renal Disease
por: Hildreth, Cara M.
Publicado: (2012)

Potential of caveolae in the therapy of cardiovascular and neurological diseases
por: Navarro, Gemma, et al.
Publicado: (2014)

Endothelial Barrier and Its Abnormalities in Cardiovascular Disease
por: Chistiakov, Dimitry A., et al.
Publicado: (2015)

Uncoupling Protein 2 in Cardiovascular Health and Disease
por: Tian, Xiao Yu, et al.
Publicado: (2018)

The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer
por: Wysocka, Marta B., et al.
Publicado: (2018)

The Role of Neuropeptide Y in Cardiovascular Health and Disease
por: Tan, Cheryl M. J., et al.
Publicado: (2018)

The Mechanobiology of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease
por: Islam, Shahrin, et al.
Publicado: (2021)

Editorial: Natural Plant Antioxidants and Cardiovascular Disease
por: Castro, Claudia
Publicado: (2022)

Intrauterine Programming of Cardiovascular Diseases in Maternal Diabetes
por: Higa, Romina, et al.
Publicado: (2021)

Efficacy and Cardiovascular Safety of Antidiabetic Medications
por: Pappachan, Joseph M.
Publicado: (2021)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
por: Cheung, BMY, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t1mm8hhggqr107q711br4htde6